# BiopharmaClaw

[![CABS: ds4cabs](https://img.shields.io/badge/CABS-ds4cabs-1f4b99?logo=github)](https://github.com/ds4cabs)
[![GitHub Pages: live](https://img.shields.io/badge/GitHub_Pages-live-brightgreen?logo=github)](https://ds4cabs.github.io/BiopharmaClaw/)
![CABS: 2026](https://img.shields.io/badge/CABS-2026-6f42c1)
![status: MVP in progress](https://img.shields.io/badge/status-MVP_in_progress-f1c40f)
![type: Biopharma Intelligence Platform](https://img.shields.io/badge/type-Biopharma_Intelligence_Platform-1f6feb)
![domain: Competitive & Scientific Intelligence](https://img.shields.io/badge/domain-Competitive_%26_Scientific_Intelligence-d63384)
![duration: 2 weeks](https://img.shields.io/badge/duration-2_weeks-0aa)

**Intern:** TBD
**Project Type:** Biopharma Intelligence Platform — AI-Powered Biopharma Intelligence Agent

## Overview
BiopharmaClaw is an **AI-Powered Biopharma Intelligence Agent** that continuously monitors the biopharmaceutical landscape and turns it into actionable insight for researchers, business leaders, and drug-development teams. It integrates multiple public data sources — PubMed, ClinicalTrials.gov, OpenFDA, LinkedIn, company press releases, SEC filings, and industry news — and uses workflow automation plus Large Language Models to collect, analyze, prioritize, and summarize information into executive-ready reports and alerts.

Unlike a generic news scraper, BiopharmaClaw is built for biopharma decision support: it links scientific publications to clinical trials, regulatory events, and corporate activity, scores relevance against the user's watched companies and therapeutic areas, and delivers source-grounded competitive intelligence on a schedule.

## Deliverable
- Automated, scheduled ingestion across PubMed, ClinicalTrials.gov, OpenFDA, SEC filings, press releases, and industry news
- Structured knowledge repository unifying scientific, clinical, regulatory, and corporate signals
- LLM-based summarization and prioritization of publications, trials, and regulatory announcements
- Emerging-target / disease-trend / competitor-movement detection
- Automated alerts for new publications, clinical milestones, regulatory events, and company announcements
- Executive-style intelligence reports with key findings and recommendations
- Automated delivery via email / Teams / Slack / SharePoint, with an optional dashboard
- (Stretch) competitor watchlists, weekly recurring briefings, and a hiring/leadership-change tracker

## Core Tools
- PubMed E-utilities (scientific literature)
- ClinicalTrials.gov API (trial monitoring)
- OpenFDA APIs (regulatory announcements, safety communications)
- SEC EDGAR (8-K / 10-K / 10-Q filings)
- Company press releases and investor-relations feeds
- LinkedIn / public company profiles (hiring & leadership signals)
- Industry news / RSS feeds
- n8n (workflow automation & orchestration)
- OpenAI API (summarization, extraction, report generation)

## Tech Stack
Python · pandas · n8n · OpenAI API · PubMed E-utilities · ClinicalTrials.gov API · OpenFDA · SEC EDGAR · requests / httpx · PostgreSQL or SQLite (knowledge repository) · vector store (pgvector / FAISS) · Streamlit / Dash (dashboard) · email / Slack / Teams / SharePoint connectors · optional LangChain / LlamaIndex.

## Notes
Two non-negotiables: (1) every quantitative or factual claim in a report must trace back to a source record (PMID, NCT-ID, FDA event, filing, or URL) — no LLM-invented facts; (2) relevance scoring against the user's watched companies and therapeutic areas is a first-class step, because alert quality and report signal-to-noise depend on it.
